EX-23.1 7 fusn-ex231_944.htm EX-23.1 fusn-ex231_944.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-239568) of Fusion Pharmaceuticals Inc. of our report dated March 25, 2021 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 25, 2021